Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
Identifying immune markers targeting stages of fibrogenesis in HIV and Hepatitis C co-infected patients
View PublicationIdentifying immune markers targeting stages of fibrogenesis in HIV and Hepatitis C co-infected patients
View PublicationComparing infectious cause hospitalization or death before 6 months of age between HEU and HIV-unexposed (HU) infants and classified for type and severity using validated study-specific case definitions
View PublicationComparing all‐cause mortality of people living with HIV and accessing care in Canada and the UK
View PublicationUnderstanding the correlates of attrition from the HIV cascade of care for women living with HIV
View PublicationDetermining the interpersonal determinants of condomless anal sex (CAS) within online-initiated sexual relationships of MSM
View PublicationReviewing HIV-specific patient-reported outcomes to produce an inventory and to identify the central concepts targeted over time
View PublicationEvaluating the sensitivity of 2 antigen/antibody immunoassays (Architect and Bioplex), 2 antibody-based rapid tests (Vikia-HIV-1/2 and Autotest-VIH), and 1 antigen/antibody rapid test (Alere HIV Combo) for the diagnosis of HIV infection
View PublicationHighlighting the need for integrated pre-exposure prophylaxis (PrEP) and nonoccupational postexposure prophylaxis (nPEP) integrated prevention programs
View PublicationIdentifying HIV clinicians’ needs for the clinical use of a new patient-reported outcome measure (PRO) on barriers to antiretroviral therapy (ART) adherence
View PublicationInvestigating temporal trends in Hepatitis C treatment uptake and evaluating factors associated with second‐generation direct acting antiretroviral initiation and efficacy among key HIV‐HCV co‐infected populations in Canada
View Publication